Event on

COVID-19 variants, vaccines and the value of rapid testing

Background

As variants evolve, vaccination gaps persist, and mask measures relax, diagnostic testing remains a cornerstone in the global fight against COVID-19. This multi-disciplinary educational program will highlight variant surveillance and testing protocols from Europe to the U.S. and explore the imperative of COVID-19 testing protocols to optimize patient care and public health readiness with an uncertain upcoming influenza season.

Learning Objectives

  • Gain expert insight on virus surveillance from the Abbott Virus Hunters, an expert team that is identifying, cataloging, and tracking evolving COVID-19 strains;
  • Learn the latest on the critical role of routine rapid testing in reducing the spread of SARS-CoV-2 and tracking highly contagious variants;
  • Review practical considerations for testing protocols and use cases in the selection of rapid antigen and molecular testing;
  • Discover ways to manage simultaneous diagnostic demands of COVID-19 and Influenza

演示文稿

  • NORMAN MOORE, PhD

    NORMAN MOORE, PhD
    (USA)
    MODERATOR

    Introduction and Presentations

    English

  • JOHN R. HACKETT JR, PhD

    JOHN R. HACKETT JR, PhD
    (USA)
    Speaker

    Meeting the challenge of viral diversity: The Abbott global viral surveillance program

    English

  • SHELDON CAMPBELL, MD, PhD

    SHELDON CAMPBELL, MD, PhD
    (USA)
    Speaker

    Direct test for virus: antigen or molecular?

    English

  • MOHAMMAD RAZA, MBBS, BSC, FRCP, FRCPath (Virology)

    MOHAMMAD RAZA, MBBS, BSC, FRCP, FRCPath (Virology)
    (UK)
    Speaker

    To NAAT or not to NAAT?

    English


所提出的观点和意见仅代表作者。 此网络广播中包含的内容仅供参考/教育目的。

© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000